THE THROMBOSIS RESEARCH INSTITUTE

Active Chelsea

Research and experimental development on biotechnology

20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
T

THE THROMBOSIS RESEARCH INSTITUTE

Research and experimental development on biotechnology

Founded 4 Sept 1987 Active Chelsea, United Kingdom 20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 16 Apr 2026 Next due 30 Apr 2026 4 days remaining
Confirmation Submitted 23 Jun 2025 Next due 28 Jun 2026 2 months remaining
Net assets £10M £206K 2024 year on year
Total assets £11M £429K 2024 year on year
Total Liabilities £1M £223K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Emmanuel Kaye Building 1b Manresa Road Chelsea London SW3 6LR

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for THE THROMBOSIS RESEARCH INSTITUTE (02161565), an active life sciences and medical technology company based in Chelsea, United Kingdom. Incorporated 4 Sept 1987. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£5.61M

Decreased by £321.37k (-5%)

Net Assets

£9.84M

Increased by £206.29k (+2%)

Total Liabilities

£1.46M

Increased by £222.73k (+18%)

Turnover

£3.12M

Increased by £1.42M (+83%)

Employees

20

Decreased by 5 (-20%)

Debt Ratio

13%

Increased by 2 (+18%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

THE THROMBOSIS RESEARCH INSTITUTE Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026OfficersAppointment of Mr Paul Howard Stacey as director on 2026-04-09
16 Apr 2026AccountsAnnual accounts made up to 2025-07-31
15 Apr 2026OfficersTermination of Diana Mary Rawstron as director on 2026-04-01
23 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-14 with no updates
3 Apr 2025AccountsAnnual accounts made up to 2024-07-31
23 Apr 2026 Officers

Appointment of Mr Paul Howard Stacey as director on 2026-04-09

16 Apr 2026 Accounts

Annual accounts made up to 2025-07-31

15 Apr 2026 Officers

Termination of Diana Mary Rawstron as director on 2026-04-01

23 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-14 with no updates

3 Apr 2025 Accounts

Annual accounts made up to 2024-07-31

Recent Activity

Latest Activity

Appointment of Mr Paul Howard Stacey as director on 2026-04-09

2 days ago on 23 Apr 2026

Annual accounts made up to 2025-07-31

1 weeks ago on 16 Apr 2026

Termination of Diana Mary Rawstron as director on 2026-04-01

1 weeks ago on 15 Apr 2026

Confirmation statement made on 2025-06-14 with no updates

10 months ago on 23 Jun 2025

Annual accounts made up to 2024-07-31

1 years ago on 3 Apr 2025